The expansion of digital health over the past 18 months has been nothing short of remarkable. But as our reliance on these health technologies grows, so too does the need for evidence to guide decisions about how, when, and where they can be used most effectively.
In celebration of Digital Health…
December 1, 2021
A new analysis of prescription drug expenditures found that total prescription drug purchases in Canada in 2020 reached $32.7 billion, an increase of 4.3% from the previous year. Additionally, over the past 20 years this spending has grown at an average annual rate of 6%, three times the average…
November 29, 2021
The CADTH Therapeutic Review of treatments for transplant-ineligible multiple myeloma patients represents several firsts for the organization. It is CADTH’s first therapeutic review in oncology, and its first involving international collaboration. It also showcases many of the progressive aspects…
November 25, 2021
Today CADTH published new recommendations that offer advice to pan-Canadian health systems on how to implement remote monitoring programs for patients with chronic cardiac conditions. These recommendations emphasize patient, caregiver, and provider considerations, data and privacy, digital equity,…
November 4, 2021
Suzanne McGurn, President and CEO of CADTH, is pleased to announce the appointment of new members of the CADTH Canadian Drug Expert Committee (CDEC) and the CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), as well as a new chair and new members of the Health…
October 8, 2021
CADTH is pleased to announce the appointment of 5 new members to the CADTH Board of Directors.
“I am pleased to welcome Hamida Bhimani, Avram Denburg, Chad Mitchell, Mark Wies, and Eric Bélair to the Board of Directors and look forward to the insight and leadership they will bring to CADTH,” said…
October 8, 2021
A statement from Suzanne McGurn, President and CEO, CADTH
On behalf of CADTH and our Board of Directors, I’m pleased to share CADTH’s Annual Report for 2020–2021, my first as President and CEO.
Read the Report
The theme of this year’s report — “unprecedented,” — is in recognition of a year like no…
October 4, 2021
In our new podcast episode, Suzanne McGurn, President and CEO of CADTH, is in conversation with Dr. Wendy Levinson, Chair of Choosing Wisely Canada — the national voice for reducing unnecessary tests and treatments in health care.
Suzanne and Dr. Levinson discuss the role of Choosing Wisely Canada…
September 21, 2021
September 17, 2021
CADTH has launched a survey to explore which new or emerging health technologies or trends could impact Canada’s health care system over the next 2 to 3 years.
The results of the survey will create awareness of potentially important and transformative health technologies and help…
September 17, 2021
August 13, 2021
CADTH welcomes today’s announcement by the Canadian Institutes of Health Research (CIHR) and Health Canada that they intend to give CADTH responsibility for the important work of the Drug Safety and Effectiveness Network (DSEN) to CADTH.
DSEN was established by CIHR and Health…
August 13, 2021
July 27, 2021
An Advisory Panel has been convened by CADTH to provide Health Canada with a recommended framework for developing a potential pan-Canadian prescription drug list, or formulary.
The Advisory Panel is composed of 2 co-chairs and 12 members. Members were recruited from across Canada and…
July 27, 2021
CADTH is now accepting abstracts for workshops, panels, debates, breakfast sessions, oral presentations, and posters for the 2021 CADTH Symposium to be held online on November 2, 3, and 4.
This year’s theme is Uncertain Times, Imperfect Evidence, and the Imperative to Act. Learn more about the…
May 18, 2021